r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

JM

James Mulay

Insider · Director · CGON

James Mulay files insider transactions with the SEC as a director of CG Oncology (CGON). We hold 5 disclosed purchases and sales filed since 28 October 2016, 2 of them in the last 90 days.

  • Files forCGON
  • Disclosed buys and sells5 in all, 2 in the last 90 days
  • Last disclosure14 July 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 4 October 2024 — 10 July 2026Director · CG Oncology (CGON)57 Form 4 lines · source: SEC Form 4
  • Filed 26 October 2016 — 30 May 2019Director · Fulgent Genetics (FLGT)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

61 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.